GlassScriptPhysician profile
Helen S Lee
NPI 1386754224
$4,804.71
in general payments reported to CMS, 2019-2025
40 companies · $692 in 2025
The $692 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $297 · 2021: $672 · 2022: $833 · 2023: $763 · 2024: $1,153 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $624.26 | 2019-2024 | |
| Biogen, INC. | $379.43 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $327.89 | 2019-2025 | Veozah |
| Shield Therapeutics INC | $326.41 | 2022-2025 | Accrufer |
| Daiichi Sankyo INC. | $299.96 | 2020-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $299.42 | 2022-2025 | |
| Pfizer INC. | $294.65 | 2020-2025 | |
| Exeltis, USA INC. | $215.05 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $208.10 | 2022-2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $200.93 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $161.73 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $160.75 | 2020-2023 | Trintellix |
| Aspira Women'S Health INC | $117.47 | 2022-2023 | Ova1 |
| Bausch Health US, LLC | $111.27 | 2019-2021 | |
| Avion Pharmaceuticals | $84.89 | 2019-2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $80.63 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $80.20 | 2020-2023 | |
| Caldera Medical, INC | $75.71 | 2021 | |
| Agile Therapeutics, INC. | $74.71 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $71.46 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $66.71 | 2019-2022 | |
| Scynexis, INC. | $61.58 | 2022 | |
| Coopersurgical, INC. | $51.32 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Pacira Pharmaceuticals Incorporated | $43.36 | 2024 | Exparel |
| Novo Nordisk INC | $39.05 | 2021-2022 | |
| Medtronic, INC. | $33.90 | 2024-2025 | Interstim, Truclear |
| Duchesnay USA Incorporated | $32.42 | 2019 | |
| Millicent US INC | $32.01 | 2025 | Intrarosa, Femring, Femlyv |
| Monaghan Medical Corporation | $31.88 | 2024 | Aerochamber |
| Lupin INC. | $29.93 | 2020-2021 | |
| Virtus Pharmaceuticals LLC | $28.30 | 2021 | |
| Northgate Technologies, INC. | $23.22 | 2024 | Stimsite |
| Optumhealth Care Solutions, LLC | $22.71 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Davol INC. | $22.58 | 2023 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $19.75 | 2020 | |
| Axonics, INC. | $17.34 | 2024 | Bulkamid |
| Merck Sharp & Dohme LLC | $15.30 | 2022 | |
| Hologic INC | $13.41 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.80 | 2019 | |
| Evofem Biosciences, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.